Covid-19 test - Import export

Water-based formulation. Innovative, skin-friendly mode of action. Immediate disinfection and long-lasting (30 days!) contamination protection in different dosage forms (spray, wipes, wash additive, foam). Broad, proven efficacy against bacteria, viruses and fungi. Special properties: The products work gently on the skin on an aqueous basis alcohol-free. After drying, the products form a long-lasting protective layer. This layer destroys germs (bacteria, fungi, yeasts and viruses) mechanically while the skin is not damaged. Therefore, germs cannot become resistant. Both efficacy and safety of the products have been extensively tested, the results - even against problematic, resistant germs - are impressive and can be provided! Particularly noteworthy is the long-lasting effect of up to 30 days on surfaces and up to 24 hours e.g. on the hands. Successfully tested against COVID-19.

Enak developed Mobile test laboratory for COVID-19 tests, antibody tests, and vaccinations, among other things. The labs can initially be used to test workers for COVID-19 at companies, government agencies, and hospitals. Depending on the result, a PCR test can be carried out in the same laboratory immediately afterwards to check the test result and, if necessary, to confirm it. The trailer can then be moved daily within a radius of several hundred miles without any problems.The laboratory has all the technical and medical equipments Same-day test results are available: within minutes for the antibody test and within a few hours for the PCR test. This type of mobile testing makes it possible for the first time to test larger groups of people under the same medical and technical conditions in a single location. In addition, the mobile labs meet the logistical and technical requirements for testing several hundred people in a short period of time If the laboratory is to remain in one

The CLUNGENE® COVID-19 Antigen Rapid Test Cassette (Nasal Swab) manufactured by Hangzhou Clongene Biotech Co., Ltd. is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in nasal swab from individuals who are suspected of COVID-19 by their healthcare provider. The COVID-19 Antigen Rapid Test is a lateral flow immunoassay based on the principle of the double­antibody sandwich technique. lf the specimen contains SARS-CoV-2 antigen, a colored test line (T) would be visible in the result window. Absence of the T line suggests a negative result. The control line (C) is used for procedural control, and should always appear if the test procedure is performed properly.

The Covid-19 Antigen Rapid Test Casserre is a lateral flow immunoassay intended fort he qualitative detection Sars-Cov-2 nucleocapsid antigens in nasophartngeal swab and orosharyngeal wsab from individuals wha are suspected of COVID-19 by their healtcare provider.

AbC-19™ is a COVID-19 (SARS-CoV-2) neutralising antibody lateral flow test and produces results in 20 minutes from a small blood sample. This flexible, easy solution confirms the presence of IgG neutralising antibodies following COVID-19 infection or vaccination: an important factor in interpreting a person’s immunity status. This reliable and accurate (Sensitivity: 98.03%, Specificity: 99.56%) test can be used by trained professionals or trained lay users. The AbC-19™ testing solution is a powerful tool for limiting risks and helping governments, individuals and businesses make more informed decisions about COVID safety and vaccine programmes. An antibody certificate smartphone app is available upon request.

The Sentebiolab Senteligo™️ SARS-CoV-2 (COVID-19) Multiplex qPCR Detection test includes a Primer-Probe set inside the Reaction Mix that contains primers and probes for human RNaseP and viral N1 and N2 regions. The internal control (primer/probe set for human RNaseP gene) is used to identify possible qPCR inhibition, confirm the integrity of the reagents, and verify the quality of RNA extraction from patient material. RNaseP primers and probes included in the kit recognize the human RNaseP gene. The primers and probes for viral N1 and N2 regions specifically identify two distinct regions on the nucleocapsid (N) gene of the SARS-CoV-2 virus. These primers and probes do not recognize the SARS-CoV virus, whose genetic structure is highly similar to SARS-CoV-2.

The TÜV-certified CLUNGSE COVID-19 antigen test is a rapid test for the qualitative detection of nucleocapsid protein antigens in nasal or nasopharyngeal swabs. The SARS-CoV-2 test listed by the BfArM may be carried out either by medical professionals or by appropriately trained professionals. The 3in1 antigen test is characterized by new batches that recognize Omikron with high specificity and are optimized for professional use. The tests are prefilled, the buffer solution bottle is sealed for error-free handling and the sample can be taken via the following swabs: nasal, oropharyngeal and nasopharyngeal. Thanks to the high sensitivity and specificity, the test result is particularly reliable. The test can already be read after 10 - 15 minutes. • 3in1 antigen test according to the Federal Institute for Drugs and Medical Devices approval AT079/20 • Format - Immunoassay​ • Sampling Nasopharyngeal swab and/or nasal • Packaging 25 tests per case